Identification of homologous human miRNAs as antivirals towards COVID‐19 genome
ADVANCES IN CELL AND GENE THERAPY · 2021
DOI: 10.1002/acg2.114 ↗Kurz gefasst
Fachartikel in der Zeitschrift ADVANCES IN CELL AND GENE THERAPY, 2021. Verfasst von Jitender Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biophysics Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh India.
- Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh India.
ORCID-Profile: Pramod K Avti
Zitieren
APA
Singh, J., Raina, A., Sangwan, N., Chauhan, A., Khanduja, K. L., & Avti, P. K. (2021). Identification of homologous human miRNAs as antivirals towards COVID‐19 genome. ADVANCES IN CELL AND GENE THERAPY. https://doi.org/10.1002/acg2.114
Vancouver
Singh J, Raina A, Sangwan N, Chauhan A, Khanduja KL, Avti PK. Identification of homologous human miRNAs as antivirals towards COVID‐19 genome. ADVANCES IN CELL AND GENE THERAPY. 2021. doi:10.1002/acg2.114
BibTeX
@article{Singh2021,
author = {Singh, Jitender and Raina, Ashvinder and Sangwan, Namrata and Chauhan, Arushi and Khanduja, Krishan L and Avti, Pramod K},
title = {Identification of homologous human miRNAs as antivirals towards COVID‐19 genome},
journal = {ADVANCES IN CELL AND GENE THERAPY},
year = {2021},
doi = {10.1002/acg2.114}
}
EUVIMED